Press Release: Valid Insight wins the Queen’s Most Coveted Award for Enterprise
- April 23, 2019
The Queen’s Awards for Enterprise are the UK’s most esteemed business awards, presented only to the most eminent of companies or individuals, demonstrating outstanding results in their field.
Today, Her Majesty the Queen announced approval of the Prime Minister’s recommendation for Valid Insight to be honoured in recognition of the outstanding success of the company’s growth strategy.
Valid Insight provides expert consultancy services that guide clients in the pharmaceutical, biotech and medical device industry to global market access success. Since being established in 2016, the company has grown exponentially, with their international client base and sales expanding by almost 800% in the last three years. In this time, they’ve also become a major brand in the market and are used by leading pharmaceutical companies worldwide.
The Queen’s Awards for Enterprise are given to businesses that have excelled and achieved significant growth and commercial success over three years. The recognition for Valid Insight follows their work with client firms across Europe, Switzerland, USA and Japan involved in the development and commercialisation of medical treatments, diagnostics and devices across multiple therapy areas.
In recognition of the honour, Valid Insight’s founder and Managing Director, Steve Bradshaw, has been invited to a Royal Reception at Buckingham Palace in June hosted by HRH The Prince of Wales.
Steve said, “We are honoured to receive the Queen’s Award for Enterprise in International Trade. We compete against a strong set of consultancy firms on a global level and to win this award means that what we are doing is world class”.
As a field-based enterprise, Valid Insight is free from any geographical limitations that restrict some of its competitors. They benefit from being able to select the best staff to provide local support, in their global operation. On top of this, services are supported by world-leading experts with decades of market access, medical and commercial experience.
Steve explains, “From the outset, our strategy was to create a competitive, truly differentiated, global strategy consulting firm with a virtual working model to attract the best talent irrespective of geography.
“We provide world-class expertise and strategic consulting solutions and tools to give the highest level of certainty around our clients’ most critical business decisions, wherever they are based”.
Valid Insight’s global network of opinion leaders, payers and expert consultants provides the pharmaceutical and life sciences industry with strategic insight and tools to assist with difficult decision making, in often complex and uncertain marketplaces. The team at Valid Insight has extensive experience in helping companies commercialise their medicinal products in all key global markets and is renowned by top pharmaceutical clients for their hands-on, senior led, pragmatic approach that produces concrete results throughout the entire life cycle of medical product development and commercialisation.
“Our flexible approach has achieved trusted partner status and repeat business with many top pharmaceutical, biotech and medical device companies worldwide. Our success is testament to the strength of our culture and the quality of our people and their commitment to fostering strong client relationships. I would like to thank our team for all their help in our recent achievements.”
Focus is firmly on the future at Valid Insight, as they continuously strive towards consolidation and growth of client relationships, optimum results and continuous innovation. To this, they have developed industry-leading technology, including an innovative digital platform that allows companies to understand the market access and price potential of a product, plus determine the focus of product development to bring optimal value at launch at very early stages of development before heavy investment is made.
Reflecting on the significance of the award, Steve said, “To win the Queen’s Award strengthens our reputation as a leader in the field and we look forward to an exciting future.
“Valid Insight continues to penetrate new global markets and is achieving ongoing success, and we continue to innovate to best serve our clients.
“This award will further encourage us to extend our high standard of expertise in the challenging area of pharmaceutical market access, helping more multinational companies bring better medicines to patients across the world”.
Read the full write up by the official Queens Award Magazine here: Valid Insight Queens Award for Trade 2019
About Valid Insight
From research to understand early opportunities, to strategic consulting and value demonstration solutions for optimal launch and to stay competitive in the market, Valid Insight is a trusted partner, and so much more.
Valid Insight specialises in providing pharmaceutical and life science companies with expert consultancy on tactical and strategic market access, product pricing and reimbursement, tender excellence, health economics and outcomes research, modelling, value demonstration tools, and training to support and optimise multinational commercial success.
They have offices in London and Belgium with a team of 10+ full time employees, plus a network of associates in all major markets worldwide.
They were the first company in the sector to offer an online platform enabling virtual strategy workshops—a digital solution called TRAVELLESS that helps multinational firms gain expert input to key business questions from global partners rapidly without the need to travel. This reduces cost and time taken to achieve results and helps improve carbon footprint while retaining the quality of insight and outputs delivered from an expert-led specialist consulting house.
Valid Insight also has access to pricing data on nearly 400,000 medicines over 38 markets, plus marketing authorisation insights for over 1 million medicines. The business has built a proprietary and extensive network of over 1,500 current and former payers, payer/HTA advisors and clinical key opinion leaders covering all major and emerging markets.
About the Queen’s Awards for Enterprise
Established in 1966, the Queen’s Awards for Enterprise recognise outstanding achievement by UK businesses and are the highest accolade for business success.
Awarded in the categories of Innovation, International Trade, Sustainable Development and Promoting Opportunity through Social Mobility, winners are announced publicly on 23 April. Winners are invited to a Royal reception and permitted to use the winners’ emblem on all marketing materials. The awards are valid for 5 years.
Applications are made in September each year, audited by qualified accountants and considered by an Advisory Committee that includes representatives of the Government, industry and commerce, and trade unions.
Previous winners of a Queen’s Award for International Trade include pharmaceutical companies Pfizer, GlaxoSmithKline, Roche Diagnostics and Eli Lilly & Company, consulting firms such as PricewaterhouseCoopers and illustrious brands such as Dyson, and Jaguar Land Rover.
Award recipients have reported benefiting from worldwide recognition, increased commercial value, greater press coverage and a boost to staff morale. (source: https://www.gov.uk/queens-awards-for-enterprise)